213 related articles for article (PubMed ID: 24718306)
1. Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes.
Loveday M; Padayatchi N; Wallengren K; Roberts J; Brust JC; Ngozo J; Master I; Voce A
PLoS One; 2014; 9(4):e94016. PubMed ID: 24718306
[TBL] [Abstract][Full Text] [Related]
2. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
[TBL] [Abstract][Full Text] [Related]
3. Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
Daftary A; Padayatchi N
Int J Tuberc Lung Dis; 2016 Nov; 20(11):1483-1488. PubMed ID: 27776589
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-EchevarrÃa A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
5. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
[TBL] [Abstract][Full Text] [Related]
6. Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.
Loveday M; Wallengren K; Voce A; Margot B; Reddy T; Master I; Brust J; Chaiyachati K; Padayatchi N
Int J Tuberc Lung Dis; 2012 Feb; 16(2):209-15. PubMed ID: 22236922
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
Chem ED; Van Hout MC; Hope V
BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive functioning in MDR-TB patients with and without HIV in KwaZulu-Natal, South Africa.
Ramlall S; Lessells RJ; Naidu T; Sandra Mthembu S; Padayatchi N; Burns JK; Tomita A
Trop Med Int Health; 2020 Aug; 25(8):919-927. PubMed ID: 32428324
[TBL] [Abstract][Full Text] [Related]
9. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
10. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah TA; Ncayiyana JR; Nyasulu PS
Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
[TBL] [Abstract][Full Text] [Related]
11. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
[TBL] [Abstract][Full Text] [Related]
12. The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature.
Geiger K; Stamper PD; Farley JE
PLoS One; 2021; 16(3):e0248174. PubMed ID: 33667271
[TBL] [Abstract][Full Text] [Related]
13. Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa.
Brust JC; Shah NS; van der Merwe TL; Bamber S; Ning Y; Heo M; Moll AP; Loveday M; Lalloo UG; Friedland GH; Gandhi NR
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):436-40. PubMed ID: 23254152
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
15. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals.
Mukonzo J; Aklillu E; Marconi V; Schinazi RF
Int J Infect Dis; 2019 Jun; 83():98-101. PubMed ID: 30991140
[TBL] [Abstract][Full Text] [Related]
17. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
Smith JP; Gandhi NR; Shah NS; Mlisana K; Moodley P; Johnson BA; Allana S; Campbell A; Nelson KN; Master I; Brust JCM
J Acquir Immune Defic Syndr; 2020 Jan; 83(1):47-55. PubMed ID: 31809360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
